|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/4415 | (2006.01) | ||
| A61K 31/4402 | (2006.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 1/08 | (2006.01) |
| (11) | Number of the document | 3326611 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17195445.6 |
| Date of filing the European patent application | 2013-02-18 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation | 2020-08-25 |
| (30) | Number | Date | Country code |
| 201261601754 P | 2012-02-22 | US |
| (72) |
VRANDERICK, Manon, CA
ST-ONGE, Jean-Luc, CA
GEDEON, Christelle, CA
GALLO, Michele, CA
GERVAIS, Éric, CA
|
| (73) |
Duchesnay Inc.,
950 Boul. Michele-Bohec, Blainville, Québec J7C 5E2,
CA
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Doksilamino ir piridoksino ir (arba) jų metabolitų ar druskų vaisto forma |
| FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND/OR METABOLITES OR SALTS THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-02-12 | 14 | 289.00 EUR |
| 2027-02-18 |